Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

Ayumi Fujimoto, MD, Fumihiro Ishida, MD PhD, Koji Izutsu, MD PhD, Satoshi Yamasaki, MD PhD, Dai Chihara, MD PhD, Junji Suzumiya, MD PhD, Tetsuo Mitsui, MD PhD, Kazuteru Ohashi, MD PhD, Hideyuki Nakazawa, MD PhD, Hikaru Kobayashi, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2019) 134 (Supplement_1): 2032.

https://doi.org/10.1182/blood-2019-122049

Published: 2019

Journal Articles

Comparison of Gold Standard Genescan with NGS-Based TCR-Beta Clonality Analysis Using Oncomine TCR Beta-Short Read Assay

Cora Husemann, Karsten Kleo, Timothy Looney, PhD, Chris Allen, Bernhard Josef Woermann, Markus Möbs, Michael Hummel

Blood (2019) 134 (Supplement_1): 4664.

https://doi.org/10.1182/blood-2019-129822

Published: 2019

Journal Articles

Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Ahmed Sawas, MD, Helen Ma, MD, Andrei Shustov, MD, Pamela Hsu, MS, Gajanan Bhat, Mark Acosta, PharmD, Steven M. Horwitz, MD, Owen A. O'Connor, MD PhD

Blood (2019) 134 (Supplement_1): 4050.

https://doi.org/10.1182/blood-2019-127155

Published: 2019

Journal Articles

Toxicity of a Modified Peg-Asparaginase-Based SMILE Regimen Is Comparable to L-Asparaginase-Based SMILE in a Non-Asian Population

Ryan J Caddell, PharmD, BCOP, Hayder Saeed, MD, Rebecca Nelson, PharmD, BCOP, Leidy Isenalumhe, MD, Julio Chavez, Celeste Bello, MD, Javier Pinilla Ibarz, MD PhD, Lubomir Sokol, MD PhD, Bijal Shah, MD

Blood (2019) 134 (Supplement_1): 5292.

https://doi.org/10.1182/blood-2019-128435

Published: 2019

Journal Articles

Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality

Paul Maciocia, BSc, MBChB, MRCP, Margarida Neves, MSc, Shimobi Onuoha, PhD, Patrycja Wawrzyniecka, Giuseppe Gritti, Manuela Tosi, Alessia Moioli, Martin Pule, MD, Teresa Marafioti, MD

Blood (2018) 132 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2018-99-112569

Published: 2018

Journal Articles

Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients with Relapsed or Refractory Multiple Myeloma (MM), Acute Myeloid Leukemia (AML), and T-Cell Neoplasms (TCL)

Blood (2018) 132 (Supplement 1): 3268.

https://doi.org/10.1182/blood-2018-99-119444

Published: 2018

Journal Articles

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Thomas M. Habermann, MD, Angelo Fama, MD, Kay M. Ristow, BS, Matthew J. Maurer, MS, William R. Macon, MD, Stephen M. Ansell, MD PhD, Nabila Nora Bennani, MD, Yogish C Kudva, MBBS, Randall C. Walker, MD, Kimberly D. Watt, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 456.

https://doi.org/10.1182/blood-2018-99-113667

Published: 2018

Journal Articles

Clonal T-Lymphocyte Populations in Healthy Donors

Kseniia A. Sychevskaia, MD, Svetlana Smirnova, MD, Yulia Sidorova, MD PhD, Natalia Ryzhikova, Andrey Sudarikov, PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 3598.

https://doi.org/10.1182/blood.V130.Suppl_1.3598.3598

Published: 2017

Journal Articles

Tumor Cells from EBV-Positive T- or NK-Cell Neoplasms Induce Differentiation and Activation of Macrophages By Secreting Humoral Factors

Akiho Tsuzura, Mayumi Yoshimori, Kanoko Konno, Ken-Ichi Imadome, PhD, Erika Onozawa, Ryunosuke Ohkawa, PhD, Minoru Tozuka, PhD, Osamu Miura, MD, PhD, Ayako Arai, MD, PhD

Blood (2017) 130 (Supplement 1): 4026.

https://doi.org/10.1182/blood.V130.Suppl_1.4026.4026

Published: 2017

Journal Articles

Genetic Activation and Therapeutic Targeting of PIM1 in T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Renate De Smedt, MSc, Sofie Peirs, PhD, Julie Morscio, PhD, Juliette Roels, MSc, Steven Goossens, PhD, Aurore Touzart, MD, Anne Uyttebroeck, Nadine Van Roy, PhD, Tim Lammens, PhD, Lara Mussolin, PhD, Elizabeth Macyntire, MD PhD, Peter Vandenberghe, MD PhD, Pieter Van Vlierberghe, PhD

Blood (2017) 130 (Supplement 1): 1445.

https://doi.org/10.1182/blood.V130.Suppl_1.1445.1445

Published: 2017

Journal Articles

Impact of Post-Transplant Lymphoproliferative Disorder Subtype on Survival

Jean L. Koff, MD, Jingxia Li, Xinyan A. Zhang, PhD MPH, Jeffrey M. Switchenko, PhD MS, Christopher Flowers, MD, Edmund K. Waller, MD

Blood (2017) 130 (Supplement 1): 1578.

https://doi.org/10.1182/blood.V130.Suppl_1.1578.1578

Published: 2017

Journal Articles

Inflammatory and Autoimmune Manifestations Associated with Lymphoid Neoplasms: A French Multicenter Retrospective Study

Vincent Jachiet, Eric Grignano, Arsène Mekinian, Paul Coppo, MD PhD, Olivier Fain

Blood (2016) 128 (22): 5335.

https://doi.org/10.1182/blood.V128.22.5335.5335

Published: 2016

Journal Articles

Excess Coincidences of Hematopoietic Neoplasms

Dominic Rose, PhD, Tamara Alpermann, Claudia Haferlach, MD, Torsten Haferlach, Wolfgang Kern, MD

Blood (2015) 126 (23): 2688.

https://doi.org/10.1182/blood.V126.23.2688.2688

Published: 2015

Journal Articles

Prognostic Relevance of Integrated Genetic Profiling in Adult T-Cell Leukemia/Lymphoma

Keisuke Kataoka, MD PhD, Yasunobu Nagata, MDPhD, Akira Kitanaka, MD PhD, Jun-ichirou Yasunaga, MDPhD, Masako Iwanaga, MD, PhD, Yuichi Shiraishi, MD PhD, Kenichi Chiba, BA, Aiko Sato-Otsubo, PhD, Masashi Sanada, MD PhD, Hiroko Tanaka, BA, Hiromichi Suzuki, MD PhD, Yusuke Sato, MD PhD, Yusuke Shiozawa, MD, Tetsuichi Yoshizato, MD, Kenichi Yoshida, MD PhD, Hideki Makishima, MD PhD, Kisato Nosaka, MD PhD, Masakatsu Hishizawa, Hidehiro Itonaga, MD PhD, Yoshitaka Imaizumi, MD PhD, Wataru Munakata, MD, Kotaro Shide, MD PhD, Yoko Kubuki, Tomonori Hidaka, Takuro Kameda, Tsuyoshi Nakamaki, MD, Ken Ishiyama, MD PhD, Shuichi Miyawaki, MD, Kensei Tobinai, MD PhD, Yasushi Miyazaki, MD PhD, Akifumi Takaori-Kondo, MD PhD, Tatsuhiro Shibata, Satoru Miyano, MD PhD, Masao Matsuoka, MD PhD, Kazuya Shimoda, MD PhD, Toshiki Watanabe, MD, PhD, Seishi Ogawa, MD PhD

Blood (2015) 126 (23): 2643.

https://doi.org/10.1182/blood.V126.23.2643.2643

Published: 2015

Journal Articles

Genomic and Targeted Mutational Analysis of T/NK-Cell Post-Transplant Lymphoproliferative Disorders Provides Insight into Disease Biology

Elizabeth Michelle Margolskee, MD, Vaidehi Jobanputra, Preti Jain, Jinli Chen, Odelia Nahum, Brynn Levy, Karthik A Ganapathi, MD PhD, Vundavalli Murty, Thomas Tousseyn, MDPhD, Bachir Alobeid, MD, Mahesh Manuskhani, MD, Govind Bhagat, MD MBBS

Blood (2015) 126 (23): 1475.

https://doi.org/10.1182/blood.V126.23.1475.1475

Published: 2015

Journal Articles

Tissue Is the Issue: Accuracy of PET Imaging to Detect Bone Marrow Clearance in Patients with Peripheral T-Cell Lymphoma

Anthony Q Pham, MD, Stephen Broski, Thomas M. Habermann, MD, Dragan Jevremovic, MDPhD, Gregory Wiseman, MD, Andrew L Feldman, MD, Matthew J Maurer, MS, Kay Ristow, Thomas E. Witzig, MD

Blood (2015) 126 (23): 3947.

https://doi.org/10.1182/blood.V126.23.3947.3947

Published: 2015

Journal Articles

Addition of Etoposide to CHOP Is Associated with Improved Outcome in Adult Anaplastic Large Cell Lymphoma Patients: A Nordic Lymphoma Group Study

Henrik Cederleuf, MD, Martin BjerregÃ¥rd Pedersen, MD PhD, Mats Jerkeman, MD PhD, Thomas Relander, MD PhD, Francesco d'Amore, MD, Fredrik Ellin, MD MSc

Blood (2015) 126 (23): 340.

https://doi.org/10.1182/blood.V126.23.340.340

Published: 2015

Journal Articles

Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies

Montreh Tavakkoli, MA, Dong H. Lee, MD, Benjamin Durham, MD PhD, Stephen S. Chung, MD, Christopher Y. Park, MD, PhD

Blood (2015) 126 (23): 2749.

https://doi.org/10.1182/blood.V126.23.2749.2749

Published: 2015

Journal Articles

Frontline Treatment of CD30+ Peripheral T-Cell Lymphomas with Brentuximab Vedotin in Combination with CHP: 3-Year Durability and Survival Follow-up

Steven M Horwitz, MD, Andrei R. Shustov, MD, Andres Forero-Torres, Nancy L Bartlett, MD, Ranjana Advani, Barbara Pro, Robert Chen, Andrew J Davies, MRCP, Tim Illidge, Dirk Huebner, Dana A. Kennedy, Michelle A. Fanale

Blood (2015) 126 (23): 1537.

https://doi.org/10.1182/blood.V126.23.1537.1537

Published: 2015

Journal Articles

Novel Gene Translocations Involving TYK2 in Cutaneous CD30-Positive Lymphoproliferative Disorders

Thirunavukkarasu Velusamy, PhD, Mark J. Kiel, MD PhD, Anagh A Sahasrabuddhe, PhD, Delphine C.M. Rolland, PharmD, PhD, Catherine A Dixon, PhD, Nathanael G. Bailey, MD, Bryan L Betz, PhD, Noah A. Brown, MD, Alexandra C Hristov, MD, Ryan A. Wilcox, MD PhD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Yoon K Jeon, MD, Megan S Lim, MD PhD, Kojo S.J. Elenitoba-Johnson, MD

Blood (2014) 124 (21): 3032.

https://doi.org/10.1182/blood.V124.21.3032.3032

Published: 2014

NARROW

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation

Comparison of Gold Standard Genescan with NGS-Based TCR-Beta Clonality Analysis Using Oncomine TCR Beta-Short Read Assay

Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Toxicity of a Modified Peg-Asparaginase-Based SMILE Regimen Is Comparable to L-Asparaginase-Based SMILE in a Non-Asian Population

Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality

Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients with Relapsed or Refractory Multiple Myeloma (MM), Acute Myeloid Leukemia (AML), and T-Cell Neoplasms (TCL)

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Clonal T-Lymphocyte Populations in Healthy Donors

Tumor Cells from EBV-Positive T- or NK-Cell Neoplasms Induce Differentiation and Activation of Macrophages By Secreting Humoral Factors

Genetic Activation and Therapeutic Targeting of PIM1 in T-Cell Acute Lymphoblastic Leukemia/Lymphoma

Impact of Post-Transplant Lymphoproliferative Disorder Subtype on Survival

Inflammatory and Autoimmune Manifestations Associated with Lymphoid Neoplasms: A French Multicenter Retrospective Study

Excess Coincidences of Hematopoietic Neoplasms

Prognostic Relevance of Integrated Genetic Profiling in Adult T-Cell Leukemia/Lymphoma

Genomic and Targeted Mutational Analysis of T/NK-Cell Post-Transplant Lymphoproliferative Disorders Provides Insight into Disease Biology

Tissue Is the Issue: Accuracy of PET Imaging to Detect Bone Marrow Clearance in Patients with Peripheral T-Cell Lymphoma

Addition of Etoposide to CHOP Is Associated with Improved Outcome in Adult Anaplastic Large Cell Lymphoma Patients: A Nordic Lymphoma Group Study

Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies

Frontline Treatment of CD30+ Peripheral T-Cell Lymphomas with Brentuximab Vedotin in Combination with CHP: 3-Year Durability and Survival Follow-up

Novel Gene Translocations Involving TYK2 in Cutaneous CD30-Positive Lymphoproliferative Disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only